Articles published in Journal of Pharmacogenomics & Pharmacoproteomics have been cited by esteemed scholars and scientists all around the world. Journal of Pharmacogenomics & Pharmacoproteomics has got h-index 12, which means every article in Journal of Pharmacogenomics & Pharmacoproteomics has got 12 average citations.

Following are the list of articles that have cited the articles published in Journal of Pharmacogenomics & Pharmacoproteomics.

  2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010

Total published articles

30 56 30 30 13 4 7 15 13 20 25 12 35 13 2

Research, Review articles and Editorials

0 6 2 4 1 1 6 14 12 17 25 12 34 7 2

Research communications, Review communications, Editorial communications, Case reports and Commentary

30 50 28 8 2 0 1 1 1 2 0 0 0 0 0

Conference proceedings

0 0 0 0 0 0 35 102 83 47 82 0 0 0 0

Citations received as per Google Scholar, other indexing platforms and portals

35 55 58 71 61 49 63 48 72 63 23 8 6 0 0
Journal total citations count 613
Journal impact factor 2.31
Journal 5 years impact factor 3.74
Journal cite score 4.86
Journal h-index 12
Important citations

Inhibition of Intestinal OATP2B1 by the Calcium Receptor Antagonist Ronacaleret Results in a Significant Drug-Drug Interaction by Causing a 2-Fold Decrease in Exposure of Rosuvastatin

A pharmacometabonomic approach to predicting metabolic phenotypes and pharmacokinetic parameters of atorvastatin in healthy volunteers

SLCO1B1 polymorphism is not associated with risk of statin-induced myalgia/myopathy in a Czech population

Pharmacogenomic and pharmacogenetic-guided therapy as a tool in precision medicine: current state and factors impacting acceptance by stakeholders

Shared pathological pathways of Alzheimer's disease with specific comorbidities: current perspectives and interventions

Pleiotropy and promiscuity in pharmacogenomics for the treatment of Alzheimer's disease and related risk factors

Pharmacogenetic considerations when prescribing cholinesterase inhibitors for the treatment of Alzheimer's disease

Gene interactions in the pharmacogenomics of Alzheimer's disease

Can cloud-based tools accelerate Alzheimer's disease drug discovery?

Pharmacogenetics of vascular risk factors in Alzheimer's disease

Genetic variants specific to aging-related verbal memory: Insights from GWASs in a population-based cohort

Pharmacogenomics of Alzheimer's and Parkinson's diseases

Opportunities in pharmacogenomics for the treatment of Alzheimer's disease

Sirtuins in alzheimer's disease: SIRT2-related genophenotypes and implications for pharmacoepigenetics

The role of pharmacogenomics in adverse drug reactions

Pharmacogenetic considerations in the treatment of Alzheimer's disease

The broad impact of TOM40 on neurodegenerative diseases in aging

Spectrum of neuromuscular disorders with hyperCKemia from a tertiary care pediatric neuromuscular center

Diagnostic evaluation of clinically normal subjects with chronic hyperCKemia

Persistent asymptomatic or mild symptomatic hyperCKemia due to mutations in ANO5: the mildest end of the anoctaminopathies spectrum